News Avacta hoping to disrupt antibody drug dominance Avacta is one of several biotechs turning their backs on mabs.
News Abbott unveils next gen point of care diagnostics Abbott hopes for launch of its Alinity suite later this year.
News Theranos unveils new technologies, but concerns linger Desktop testing device and cloud-based diagnostic platform announced.
News Programmable lab-on-chip advancing in trials A digital device the size of a credit card could provide a diagnosis in just minutes for a huge range of conditions.
News Theranos appoints new execs, compliance board Under-fire diagnostics firm tightens regulatory and compliance efforts
News IBM recruited to improve medical imaging The collaboration will aim to personalise care and address financial inefficiencies.
News BridgeBio poised to challenge Pfizer after Attruby approval BridgeBio grabs FDA approval for its ATTR cardiomyopathy drug Attruby, setting up a challenge to market leader Pfizer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
